BlogHeader.png

Panel Discussion: Oral Solid Dosage Manufacturing Process 

Alcami recently contributed to Pharma Horizon's first Panel Discussion of 2018, dedicated to the Oral Solid Dosage (OSD) Manufacturing Process. 

The topics discussed include main challenges that manufactures of OSD forms have to face, such as quality, safety and productivity, as well as technical advancements, production management, operational excellence aspects, tech transfer, and packaging operations.

Topics: Thought Leadership Editorials Manufacturing Oral Solid Dose

Alcami Supports STEM Education at Local High School

Experts from Alcami’s Germantown, Wisconsin active pharmaceutical ingredient (API) Center of Excellence teamed up with Germantown High School engineering and honors biology students Monday, February 26, 2018, in Germantown, Wisconsin, for a Day of STEM (Science, Technology, Engineering, and Math) – part of an ongoing series of educational presentations promoting the importance of careers in science, technology, engineering, and math.

Topics: Company News Alcami in Action Manufacturing

Editorial: Oral Solid Dosage Manufacturing Roundtable

Alcami recently contributed to a roundtable featured in Pharmaceutical Outsourcing magazine titled "Oral Solid Dosage Manufacturing Roundtable." The article discusses a variety of topics including current critical issues facing the industry in regards to oral solid dosage manufacturing, new manufacturing technologies/processes, the affect that globalization of the pharma industry has had on oral solid dose manufacturing, and more.

Topics: Thought Leadership Editorials Oral Solid Dose Manufacturing

Editorial: Formulation Development & Manufacturing — CDMOs Offer Speed, Advanced Technologies, & the Ability to Handle More Potent APIs

Alcami recently contributed to a special feature in Drug Development and Delivery magazine titled "Formulation Development & Manufacturing — CDMOs Offer Speed, Advanced Technologies, & the Ability to Handle More Potent APIs." The article includes Alcami, along with other CDMOs highlighting their capabilities in the areas of speed, quality, technology, and handling of complex APIs.

Topics: Thought Leadership Editorials CDMO Development Manufacturing

Editorial: Alcami Featured in Pharma Horizon's January 2017 Issue

Syed Husain, Alcami CCO is featured in an article published in Pharma Horizon's January 2017 issue. The article, written by Cynthia Challener, Scientific Content Director at That's Nice, LLC discusses next-generation therapies: overcoming bioprocessing, characterization and logistics challenges. 

Topics: Thought Leadership Editorials CDMO Manufacturing